Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor-experienced patients with hepatitis C: Real-world data from a multicenter Asian registry.
作者信息
Wong Y J, Kumar R, Kumar R, Tan J, Liu C H, Hui Vw-K, Tan S S, Kao J H, Wong Gl-H, Thurairajah P H
机构信息
Changi General Hospital, Changi, Singapore.
Duke-NUS Medicine Academic Clinical Program, Singhealth, Singapore.
出版信息
J Gastroenterol Hepatol. 2022 Aug;37(8):1642-1644. doi: 10.1111/jgh.15918. Epub 2022 Jun 30.
Abstract
摘要
Zotero 插件